Victoza (Liraglutide) Solution For Injection, 6 MG/ML


Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 67.0%
Product Used For Unknown Indication 26.3%
Diabetes Mellitus 4.1%
Weight Decreased 1.0%
Glucose Tolerance Impaired 0.6%
Type 1 Diabetes Mellitus 0.6%
Metabolic Syndrome 0.3%
Nausea 27.8%
Blood Glucose Increased 11.5%
Pancreatitis 8.6%
Weight Decreased 7.2%
Vomiting 5.7%
Injection Site Haematoma 5.3%
Injection Site Pain 4.3%
Diarrhoea 3.8%
Drug Ineffective 3.3%
Headache 2.9%
Blood Glucose Decreased 2.4%
Constipation 2.4%
Dyspnoea 2.4%
Malaise 2.4%
Fatigue 1.9%
Injection Site Urticaria 1.9%
Urticaria 1.9%
Abdominal Discomfort 1.4%
Flatulence 1.4%
Injection Site Erythema 1.4%
Secondary
Type 2 Diabetes Mellitus 66.7%
Product Used For Unknown Indication 13.3%
Type 1 Diabetes Mellitus 13.3%
Weight Decreased 6.7%
Blood Glucose Decreased 14.3%
Blood Glucose Increased 14.3%
Flatulence 14.3%
Injection Site Rash 14.3%
Pain In Extremity 14.3%
Sluggishness 14.3%
Tremor 14.3%

Drug Data